U.S. pauses Eli Lilly antibody drug trial over safety concern
U.S. pauses Eli Lilly antibody drug trial over safety concern

Eli Lilly and Co said on Tuesday that the government-sponsored clinical trial of its COVID-19 antibody treatment similar to one taken by U.S. President Donald Trump has been paused because of a safety concern.

This report produced by Jillian Kitchener.